Vaccine Efficacy Testing

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

The spray primes lung immune cells with T‑cell‑like signals to mount rapid, non‑specific defenses across respiratory threats.